IT1274012B - N-acetiltriptamine-2-sostituite, antagoniste ad elevata affinita' del recettore della melatonina - Google Patents

N-acetiltriptamine-2-sostituite, antagoniste ad elevata affinita' del recettore della melatonina

Info

Publication number
IT1274012B
IT1274012B ITMI940223A ITMI940223A IT1274012B IT 1274012 B IT1274012 B IT 1274012B IT MI940223 A ITMI940223 A IT MI940223A IT MI940223 A ITMI940223 A IT MI940223A IT 1274012 B IT1274012 B IT 1274012B
Authority
IT
Italy
Prior art keywords
antagonists
high affinity
acetyltriptamine
substituted
melatonin receptor
Prior art date
Application number
ITMI940223A
Other languages
English (en)
Inventor
Franco Fraschini
Bojidar Stankov
Aldo Laguzzi
Gilberto Spadoni
Original Assignee
I F L O Istituto Farmacologico
Bojidar Stankov
Franco Fraschini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by I F L O Istituto Farmacologico, Bojidar Stankov, Franco Fraschini filed Critical I F L O Istituto Farmacologico
Priority to ITMI940223A priority Critical patent/IT1274012B/it
Publication of ITMI940223A0 publication Critical patent/ITMI940223A0/it
Publication of ITMI940223A1 publication Critical patent/ITMI940223A1/it
Application granted granted Critical
Publication of IT1274012B publication Critical patent/IT1274012B/it

Links

Landscapes

  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invenzione si riferisce all'impiego della 2-bromo-N-acetiltriptamina e della 2-fenil-N-acetiltriptamina come antagonisti ad elevata affinità del recettore della melatonina, per la preparazione di composizioni farmaceutiche atte al trattamento di situazioni associate ai cicli circadiani e stagionali nell'uomo e negli animali.
ITMI940223A 1994-02-08 1994-02-08 N-acetiltriptamine-2-sostituite, antagoniste ad elevata affinita' del recettore della melatonina IT1274012B (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITMI940223A IT1274012B (it) 1994-02-08 1994-02-08 N-acetiltriptamine-2-sostituite, antagoniste ad elevata affinita' del recettore della melatonina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940223A IT1274012B (it) 1994-02-08 1994-02-08 N-acetiltriptamine-2-sostituite, antagoniste ad elevata affinita' del recettore della melatonina

Publications (3)

Publication Number Publication Date
ITMI940223A0 ITMI940223A0 (it) 1994-02-08
ITMI940223A1 ITMI940223A1 (it) 1995-08-09
IT1274012B true IT1274012B (it) 1997-07-14

Family

ID=11367799

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI940223A IT1274012B (it) 1994-02-08 1994-02-08 N-acetiltriptamine-2-sostituite, antagoniste ad elevata affinita' del recettore della melatonina

Country Status (1)

Country Link
IT (1) IT1274012B (it)

Also Published As

Publication number Publication date
ITMI940223A0 (it) 1994-02-08
ITMI940223A1 (it) 1995-08-09

Similar Documents

Publication Publication Date Title
EP0458079A3 (en) Ultrasonic contrast agent, its preparation and application as diagnostic or therapeutic
AP2000001785A0 (en) Medicaments
DE69027057D1 (de) Retinal, dessen Derivate und deren therapeutische Verwendung
CS553490A3 (en) Transdermal therapeutic system
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
GB9317104D0 (en) Therapeutic heterocycles
HK1050319A1 (en) Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ES2082587T3 (es) El uso de l-deprenyl para la fabricacion de un medicamento para el tratamiento de la enfermedad de cushing.
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
DK0582900T3 (da) Arbejdsområdelampe til den medicinske, især tandmedicinske praksis
DK0582897T3 (da) Arbejdsområdelampe til den medicinske, især tandmedicinske praksis
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
IL118218A0 (en) Terpenoidic derivatives and pharmaceutical compositions containing them
FI973185A (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
IT1274012B (it) N-acetiltriptamine-2-sostituite, antagoniste ad elevata affinita' del recettore della melatonina
ES2150418T3 (es) Composiciones farmaceuticas que comprenden calcitonina.
DE69331008D1 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
ES1034986Y (es) Aparato para el tratamiento del cuerpo humano.
RU97115054A (ru) Средство для лечения онкологических больных
MXPA01006319A (es) Uso de los antagonistas del receptor para 5ht, para el tratamiento de sindrome de fatiga cronica.
NO882724L (no) Smertepreparat.
IL156144A0 (en) Novel therapeutic use of a thienylcyclohexylamine derivative
BR9812489A (pt) Uso de 6,7-substituìdas-2-aminotetralinas adequadas para a preparação de uma composição farmacêutica para o tratamento terapêutico de patologias inflamatórias e/ou autoimunes
ZA981275B (en) Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970730